Mendelspod Podcast

The Reboot of Consumer Genomics? with Kian Sadeghi, Nucleus Genomics

06 Aug 2024

Contributed by Lukas

There’s a new company in the consumer genomics space that last month released results for the first adopters of its new consumer-facing whole genome...

From Geospatial to Biospatial: Avi Veidman of Nucleai

25 Jul 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comAvi Veidman spent over 20 years in the IDF (Israel Defense Forces), le...

New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio

18 Jul 2024

Contributed by Lukas

Yuling Luo is a serial entrepreneur who has founded three significant companies in life science tools. Most recently, he is the founder and CEO of Ala...

Diagnostic Trends in 2024 with Mara Aspinall, Illumina Ventures

27 Jun 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comOne might think the pandemic would have been good for diagnostic compa...

The Actionable Epigenome with Bret Barnes, Illumina

18 Jun 2024

Contributed by Lukas

The genome has been the core focus of biomedical research for twenty years. Although the genome is prewritten and predetermined, much biology happens ...

Not All Prenatal Screens Are the Same: Jennifer Hoskovec, Billion to One

13 Jun 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comNot content to offer “me too” products, a new company in the prena...

Harvard's Marc Lipsitch on the New White House Policy Regulating Risky Pathogen Research

04 Jun 2024

Contributed by Lukas

This week, we saw Dr. Anthony Fauci being grilled by an angry congress over, among other things, the origin of COVID-19, which is estimated killed at...

Liquid Biopsy Goes Beyond Cancer: Diana Abdueva and Maggie Louie, Aqtual

23 May 2024

Contributed by Lukas

A new precision medicine startup has launched that uses transcriptomic and epigenetic information to help with therapy for a wide range of chronic dis...

Cell Therapy Will Transform Medicine as We Know It, Says Jason Bock, CTMC

16 May 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comToday, we pursue an exciting area of medicine for the first time:  ce...

Two Industry Leaders on Dealing with the Growing Complexity of Genomic Cancer Data

14 May 2024

Contributed by Lukas

The Clinical Knowledge Base (CKB) powered by The Jackson Laboratory (JAX) is a dynamic digital resource for interpreting complex cancer genomic profil...

Single Cell Spatial Proteomics with Filip Karlsson, Pixelgen

09 May 2024

Contributed by Lukas

A paper out this week in Nature Methods demonstrates a new technology which shows novel patterns of protein spatial polarization and co-localization i...

The Precision Medicine Optimist: Damon Hostin, Illumina

07 May 2024

Contributed by Lukas

Damon Hostin has had an active and exciting journey in genomic medicine.  He’s now at Illumina, where his title is illuminative:  Lead, Health Sys...

An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer

02 May 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comSarah LeBaron von Baeyer studied anthropology at Yale. Today she serve...

How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina’s AI Lab, Kyle Farh

30 Apr 2024

Contributed by Lukas

In today’s show, we talk with Kyle Fahr, the VP and Distinguished Scientist leading Illumina’s Artificial Intelligence Lab."We lack a way of train...

The Pre-Symptomatic Space with Patrick Short, Sano Genetics

25 Apr 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comToday, we continue our look into the gap in the adoption of precision ...

Systemwide Implementation of Precision Medicine at UCHealth with David Kao

18 Apr 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comThrough its Center for Personalized Medicine, the University of Colora...

Is this New Tech a Game Changer for Spatial Biology?

11 Apr 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comA  new spatial biology company is promising to shake up the field. L...

Synthetic Biology in 2024 with John Cumbers

26 Mar 2024

Contributed by Lukas

John Cumbers is back on the show to preview the annual SynBioBeta, the leading global conference for the synthetic biology crowd. This year’s show i...

Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom

21 Mar 2024

Contributed by Lukas

Most of the news coming from Illumina has had to do with their leadership in the sequencing instrument space. What is lesser known is that they offer ...

The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo

19 Mar 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comToday, we feature a new DNA synthesis company out of Sweden that is ma...

Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy

12 Mar 2024

Contributed by Lukas

The rise of RNA therapeutics and cell therapies promises to take us where we’ve never been in medicine.  The growing understanding of RNA, mRNA, an...

Precision Medicine for Dogs: Christina Lopes, OneHealth

22 Feb 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 Number one unmet medical need for dogs6:25 Using “extr...

Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome

15 Feb 2024

Contributed by Lukas

There’s a new genome editing company that everyone is talking about this year.  Tome Biosciences came out of stealth in December, claiming the abil...

Christian Henry of PacBio on Long Reads at Scale, Next Moves

13 Feb 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com0:00 Long reads at scale has made what difference?6:15 The long ...

Robert Michel, Editor at The Dark Report, on Gap in Genetic Testing

06 Feb 2024

Contributed by Lukas

Why aren’t more folks receiving genetic testing?In a study published in JAMA last year, Stanford cancer researcher Alison Kurian found a surprising ...

Turning to Next Gen Proteomics for Novel Biomarkers: Jon Brudvig and Bruce Wilcox

30 Jan 2024

Contributed by Lukas

Batten disease is a group of neurodegenerative lysosomal storage disorders that result from pathogenic variants in one of 13 CLN genes. Collectively, ...

What Have We Learned from the Brain Map Project So Far? with Tom Nowakowski, UCSF

23 Jan 2024

Contributed by Lukas

After ten years, the human brain mapping project has achieved some major milestones, says Tom Nowakowski, a researcher at UCSF, on today’s program. ...

Quality Healthcare Should Not Depend on Which Book Club You Attend, Karen Tumulty of the Washington Post

16 Jan 2024

Contributed by Lukas

Karen Tumulty, a political writer for the Washington Post, was diagnosed with multiple myeloma. She was told she had five years to live.  Then she we...

Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics

09 Jan 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comFun fact:  we are composed of 90% bacterial cells and 10% human cells...

Todd Druley of Mission Bio on Single Cell Multi-Omics

04 Jan 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com"We can now begin to look at disease before it happens,” says today’...

Kevin Davies on Gene Therapy in 2023

26 Dec 2023

Contributed by Lukas

This month, the FDA approved the first CRISPR-based gene therapy called Casgevy (pronounced with a soft g). It’s a one-and-done treatment for sickl...

History and State of Proteomics 2023 with John Yates

19 Dec 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comMany of our shows this year have explored a new wave of proteomics too...

New Philosophy of Biology Series on PBS: A Preview with Host Robert Lawrence Kuhn

12 Dec 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comThis month, a new philosophy of biology series premiers on PBS hosted ...

Mapping the Meta Proteome: John Shon, CTO, Serimmune

05 Dec 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comJohn Shon is the Chief Technology Officer at Serimmune, a company spec...

Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech

28 Nov 2023

Contributed by Lukas

Our guest today introduced us to a new kind of immunotherapy called Super-NK.  Imagine CAR-T, but in this case, the immune cells from the patient are...

Chris Hall and Rich Chen of Personalis on Next Gen MRD Testing

21 Nov 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comPersonalis, a company launched during the early days of whole genome t...

State of Sequencing 2023: Shawn Baker and Keith Robison

14 Nov 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 Delivering on last year’s announcements8:50 Illu...

Newborn Sequencing 2023 Part II: What Evidence Is Enough?

07 Nov 2023

Contributed by Lukas

Chapters:0:00   State of the field: reviewing ICoNS conference22:20 What evidence is enough?Today, we’re joined by a panel of four guests who h...

Lincoln Nadauld on the State of Precision Medicine in 2023

17 Oct 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 Precision oncology is standard of care13:50 Culminat...

Nothing Is "Undruggable:" Alex Federation, CEO, Talus Bio

12 Oct 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 What are transcription factors?7:00 The MARMOT p...

Mass Spec Advances in a New Age of Proteomics: Rosy Lee, Thermo Fisher Scientific

10 Oct 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 Attending this year’s Human Proteome Organization (...

This Is Very Cool: Treating Cancer with Sound

03 Oct 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 What does treatment look like?7:25 Light treatme...

The Future of Clinical Proteomics with Jenny Van Eyk and Daniel Hornburg

27 Sep 2023

Contributed by Lukas

Chapters:0:00  “It’s a magical time.”9:55 Tracking low-concentration proteins in real-time19:20 What next?24:40 Proteins act in com...

Elinor Karlsson on Darwin’s Ark

18 Sep 2023

Contributed by Lukas

Today’s show is made free by the generous support of Twist Bioscience. Twist works in service of people changing the world for the better in fields...

Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech

13 Sep 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 World’s longest oligo8:45 Why is it difficult to...

Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences

05 Sep 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comChapters:0:00 Novel Cas enzymes help overcome CRISPR challenges11:3...

13th Season Opener: Mike Snyder on Microsampling and Multi-Omic Profiling

24 Aug 2023

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com0:00 Latest paper on multi-omics microsampling6:30 Is it useful? ...

Gene Patent Decision at 10 Years, State of Genetic Testing with Ellen Matloff, My Gene Counsel

15 Jun 2023

Contributed by Lukas

Ten years ago this week, the Supreme Court unanimously ruled that genes could not be patented. This is a public episode. If you'd like to discuss this...

Proteomics Bigger than Genomics, It’s Just Taking Time, Says Jeff Hawkins, CEO, Quantum-SI

01 Jun 2023

Contributed by Lukas

Today we feature Quantum-SI, one of the new wave of proteomics tools companies.  The company was founded by serial life science entrepreneur, Jonatha...

Biden, AI, and DeSci: John Cumbers Previews SynBioBeta 2023

09 May 2023

Contributed by Lukas

SynBioBeta is the largest gathering of the synthetic biology community worldwide.  It’s taking place May 23-25 in Oakland, California.  John Cumbe...

Proteomics Today Where Genomics Was in the 80s: Margaret Donovan and Asim Siddiqui of Seer on Landmark Study

08 May 2023

Contributed by Lukas

It’s a thrilling time to be in proteomics.  Today we discuss a recent paper in PLOS One demonstrating how new technology has revealed a novel bioma...

Is This New Platform an Answer to the Reproducibility Crisis? with Guy Rohkin

27 Apr 2023

Contributed by Lukas

Philosophers talk about various kinds of knowledge.  There is knowing that something is.  We learn that the sun is 90 million miles from the Earth...

Elegen Pioneers Long DNA Subindustry with CEO Matt Hill

19 Apr 2023

Contributed by Lukas

Long DNA has arrived.   Elegen, a new company based in San Carlos, California,  is out this year offering just long DNA.  According to their founde...

Nevermind the $200 Genome, Element CEO Molly He Says Core Chemistry Capable of Much More

23 Mar 2023

Contributed by Lukas

"We’re not a sequencing company," says Molly He, CEO and co-founder of Element Biosciences in our first interview with the leader of the hot new seq...

3D Genomics Solves Cancer Case Where Sequencing Came Up Short: Anthony Schmitt, Arima Genomics

16 Mar 2023

Contributed by Lukas

Biology is complex, and the life science tool kit continues to expand to meet the challenge of that complexity taking us into the world of multi omics...

New Spatial Company Maps Cell Surface Proteome without Imaging

08 Mar 2023

Contributed by Lukas

Today we talk with Simon Fredriksson, CEO and co-founder of Pixelgen Technologies, a company just out of stealth offering spatial technology that maps...

John Greally on His Latest Review of Epigenomics

23 Feb 2023

Contributed by Lukas

Editor's Note: Theral's mic malfunctioned in this interview. Fortunately the not as good backup mic did work and John has a good mic.  Our apologies....

President of ASHG on Eugenics Apology, Diversity Initiative

15 Feb 2023

Contributed by Lukas

Last month the American Society of Human Genetics (ASHG) took a quite remarkable step, putting out a formal statement of apology for its past history ...

23andMe Launches New Personalized Healthcare Initiative with Amy Sturm

02 Feb 2023

Contributed by Lukas

23andMe occupies its own place in the world of genomics. Known for its vision to democratize human genomic information, the company has always gone b...

Converting Digital to Biological: John Gill, Telesis Bio

23 Jan 2023

Contributed by Lukas

Remember all those firsts for synthetic biology that we heard about coming from Craig Venter’s company, Synthetic Genomics in San Diego? The first ...

50% Not Tested: Precision Oncology with Jerome Madison, Invitae

17 Jan 2023

Contributed by Lukas

Oncology has emerged as the most successful disease area for precision medicine. Last year, as the genetic testing industry went through a royal shak...

Paul Freemont on Synthetic Biology in the UK

05 Jan 2023

Contributed by Lukas

To begin the year, we head across the pond for an outlook on the thriving community of synthetic biology in the United Kingdom.Paul Freemont was a co-...

The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics

22 Dec 2022

Contributed by Lukas

Our goal with today’s show was twofold: bring you a practical holiday gift idea and to take you into the world of a synthetic biology entrepreneur....

Lance Baldo of Freenome on their Approach to Early Cancer Detection

08 Dec 2022

Contributed by Lukas

When excitement around early cancer detection first surfaced, we heard about the “pan-cancer” test that would look for any and all cancers, and ea...

Mara Aspinall on COVID

29 Nov 2022

Contributed by Lukas

Winter is here.  In America, we're just back from the Thanksgiving holiday when many of us travel and get together.  And so far there is no great CO...

Terry Lo of Vizgen on Spatial Genomics

27 Nov 2022

Contributed by Lukas

Today spatial biology company, Vizgen, makes their debut on on the program.When Vizgen CEO Terry Lo was first involved in developing what we now call ...

Proteomics at Scale Empowers Genomics in New Ways: Dale Yuzuki, Olink

22 Nov 2022

Contributed by Lukas

It’s the age of multi omics. Or multi comics, if you don't catch spell check. A few weeks ago at the annual meeting of the American Society for Hu...

A New Tool in the Genomics Kit with Ivan Liachko of Phase Genomics

14 Nov 2022

Contributed by Lukas

Have you ever heard of proximity ligation? We knew of it in research form back in the day, but not that it had been commercialized until this summer...

Paul Kruszka of GeneDx/Sema4 on Groundbreaking Newborn Sequencing Study

13 Nov 2022

Contributed by Lukas

Last week, during the first International Conference on Newborn Sequencing, a landmark study to sequence the genomes of 100,000 newborns was announced...

Is PGx Having a Moment? Kristine Ashcraft, Invitae

10 Nov 2022

Contributed by Lukas

Pharmacogenomic testing, or PGx, is considered low-hanging fruit, a no-brainer for the application of genetic testing in the clinic. And some may th...

Christian Henry on Revio, Onso and the New Vision at PacBio

03 Nov 2022

Contributed by Lukas

Last week with a crowd of 1,200 customers in a Los Angeles nightclub, sequencing company Pacific Bioscience launched two new sequencers, both long and...

The Revolution in Single Molecule Sequencing Continues: Vijay Ramani, UCSF

18 Oct 2022

Contributed by Lukas

A new generation of biologists is pushing the limits of third-generation sequencing, furthering the technology's development and defining new applicat...

Will Hwang of Mass General on Discovery of Novel Pancreatic Cancer Cell Subtype

11 Oct 2022

Contributed by Lukas

In our age of specialization, today’s guest, Dr. Will Hwang of Massachusetts General, went against the trend and received three bachelor degrees in ...

Going Beyond Time Barriers: Arutha Kulasinghe on the Power of New Spatial Biology Tools

07 Oct 2022

Contributed by Lukas

Arutha Kulasinghe was pumped for the AGBT (Advances in Genome Biology and Technology) Conference this year. He is the Principal Investigator for the ...

Invitae’s Data Manager, Farid Vij, on New Genome Management Platform

22 Sep 2022

Contributed by Lukas

One thinks of Invitae as a leading genetic testing company that has worked to improve clinical quality while bringing prices down. And they are, and ...

Satellite Bio out with a New Tissue Based Approach to Regenerative Medicine

25 Aug 2022

Contributed by Lukas

Satellite Bio is named descriptively for the way its platform works. Out of stealth in the past few months with what you might call a middle ground a...

We Have to Get Sequencing Back to Moore’s Law: Gilad Almogy, Ultima Genomics

23 Jun 2022

Contributed by Lukas

There was a tweet thread at the end of the recent Advances in Genome Biology and Technology (AGBT) conference where researchers took a moment of silen...

RNA Therapeutics: A New Paradigm for Drug Development? Tim Mercer, BASE Lab, U of Queensland

16 Jun 2022

Contributed by Lukas

Has the pandemic unleashed the molecule of RNA to be the new future of drug development?Tim Mercer is the Director of the BASE Lab at the University o...

The System is Working. We Need More Engagement, Says ClinVar Champion Heidi Rehm of Mass General in Her Update on the State of Genomic Medicine in 2022

09 Jun 2022

Contributed by Lukas

Heidi Rehm’s talents for genomics are legendary. Our field has devoured them like a hungry beast.Discovering an appreciation for the natural logic ...

The Promise of Exosomes Now Realized, Says Paul Billings, CEO, Biological Dynamics

02 Jun 2022

Contributed by Lukas

The area of early cancer detection continues to become ever more exciting these days. Each month more companies add liquid biopsies to their product o...

Lee Cronin on Origin of Life, Genomics, Aliens and More

01 Jun 2022

Contributed by Lukas

While we’re able to sit outside on a warm summer’s night under the ocean of stars, let us contemplate some of the bigger questions. We’re very e...

Eric Green on the Future of the NHGRI

28 May 2022

Contributed by Lukas

Dr. Eric Green has been the Director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) since 2009. T...

5-Base Sequencing: Jonas Korlach and Tomi Pastinen

25 May 2022

Contributed by Lukas

Pacific Biosciences has introduced a new method for detecting DNA methylation simultaneously with DNA sequencing. They are calling it 5-base sequenci...

More Cancer Patients Die from Infections than Cancer, Says Alec Ford, CEO of Karius

18 May 2022

Contributed by Lukas

Alec Ford is passionate about his message. No wonder. There's an astounding fact in cancer medicine that is little known and could make a big differ...

Some of the Lowest Hanging Fruits in Precision Medicine: Michelle Whirl-Carrillo on Pharmacogenomics

10 May 2022

Contributed by Lukas

One of the underrated but true successes of precision medicine has been pharmacogenomics. Beginning in the ’90s with the approval of the drug Herc...

John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA

14 Apr 2022

Contributed by Lukas

Today we talk with John Nelson, Senior Principal Scientist at GE Research and veteran in the field of DNA synthesis. On January 7th, 2020, two weeks ...

A New Generation Comfortable Doing a Thousand Things at a Time Is Reinventing Life Science Says Joe Beechem of NanoString

07 Apr 2022

Contributed by Lukas

“I’ve seen a lot of revolutions. Now we’re at the beginning of spatial biology, and I think it has the chance to transform life science similar...

Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.

31 Mar 2022

Contributed by Lukas

Are we now entering the age of proteomics the way we did with genomics thirty years ago?We were told we should talk to today’s guest by four people ...

The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae

17 Mar 2022

Contributed by Lukas

"There's an entire field of fragmentomics with a whole lot of people working on it. The DNA which is shed into the bloodstream has a certain length. ...

The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script

03 Mar 2022

Contributed by Lukas

The DNA synthesis space is seeing some real creativity and disruption this past year. One newcomer, in particular, is shaking things up.Sylvain Garie...

Akoya Biosciences Launches New Integrated Spatial Platform: Our First Interview with CEO Brian McKelligon

24 Feb 2022

Contributed by Lukas

Even though Brian McKelligon calls himself a rookie CEO, he comes to the top position at Akoya Biosciences with a veteran’s resume. His path to on...

Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity

16 Feb 2022

Contributed by Lukas

Harlan Robins is the Chief Scientific Officer at Adaptive Biotechnologies in Seattle. In 2014, Harlan and his brother Chad co-founded Adaptive as a s...

Twist Bioscience: A New Kind of DNA Synthesis Company

10 Feb 2022

Contributed by Lukas

“DNA is changing everything for the better,” says today’s guest, Emily Leproust, CEO of Twist Bioscience. Twist has emerged at the heart of what...

Going High Resolution with 10X Genomics: Michael Schnall-Levin

27 Jan 2022

Contributed by Lukas

Working at the Broad Institute early in his career, Michael Schnall Levin was discovering he was a biologist at heart. He’d begun his studies in ph...

George Church and Ben Lamm on the Launch of Colossal Biosciences

20 Jan 2022

Contributed by Lukas

According to scientists, 30,000 species per year are going extinct. That’s 6 an hour, 150 per day. Up to one half of all species could be extinct ...

We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years

21 Dec 2021

Contributed by Lukas

Chris Mason is back on the program for our end-of-year special. He’s Professor of Genomics, Physiology, and Biophysics at Weill Cornell School of Me...

Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership

07 Dec 2021

Contributed by Lukas

In a joint interview, Sean George, CEO of diagnostics firm, Invitae, and Christian Henry, CEO of sequencing tools company, Pacific Biosciences, say th...

Building on the Knowledge Base of Developer Community, LuminexPLORE Lab Offers Custom Insights: Jackie Surls, Director

30 Nov 2021

Contributed by Lukas

There are some technologies that become so ubiquitous in biomedical research that their name turns synonymous with their use. This has been the case ...

DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO

17 Nov 2021

Contributed by Lukas

DNA is a multibillion-dollar industry in 2021 and satisfies many life science applications, including drugs, reagents, siRNA, PCR, diagnostics, synthe...

Tumor Evolution in Context with Christina Curtis

11 Nov 2021

Contributed by Lukas

If one was going to be a cancer researcher, surely one would want to be Christina Curtis. She’s an associate professor of oncology and genetics at ...